CA2259986A1 - Radicaux a anions oxygene et/ou substances therapeutiques contenant leurs produits de reaction et de degradation et leur utilisation dans le traitement de la maladie de parkinson - Google Patents

Radicaux a anions oxygene et/ou substances therapeutiques contenant leurs produits de reaction et de degradation et leur utilisation dans le traitement de la maladie de parkinson Download PDF

Info

Publication number
CA2259986A1
CA2259986A1 CA 2259986 CA2259986A CA2259986A1 CA 2259986 A1 CA2259986 A1 CA 2259986A1 CA 2259986 CA2259986 CA 2259986 CA 2259986 A CA2259986 A CA 2259986A CA 2259986 A1 CA2259986 A1 CA 2259986A1
Authority
CA
Canada
Prior art keywords
oxygen anion
parkinson
anion radicals
treatment
tremor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2259986
Other languages
English (en)
Inventor
Naum Goldstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Goldstein & Lewin Technology GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2259986A1 publication Critical patent/CA2259986A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des radicaux à anions oxygène et/ou des substances thérapeutiques contenant leurs produits de réaction et de dégradation. L'invention concerne également leur utilisation dans le traitement de la maladie de Parkinson. Le principal objectif est de réduire ou d'éliminer les tremblements typiques de la maladie de Parkinson mais qui peuvent également apparaître avec d'autres maladies ou tout simplement sous forme de tremblements "séniles".
CA 2259986 1997-02-20 1998-02-17 Radicaux a anions oxygene et/ou substances therapeutiques contenant leurs produits de reaction et de degradation et leur utilisation dans le traitement de la maladie de parkinson Abandoned CA2259986A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19708643.8 1997-02-20
DE1997108643 DE19708643C2 (de) 1997-02-20 1997-02-20 Verwendung von Sauerstoffanionradikalen und/oder deren Folge- und Abbauprodukte zur Behandlung von Morbus Parkinson

Publications (1)

Publication Number Publication Date
CA2259986A1 true CA2259986A1 (fr) 1998-08-27

Family

ID=7822112

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2259986 Abandoned CA2259986A1 (fr) 1997-02-20 1998-02-17 Radicaux a anions oxygene et/ou substances therapeutiques contenant leurs produits de reaction et de degradation et leur utilisation dans le traitement de la maladie de parkinson

Country Status (7)

Country Link
EP (1) EP0910392A2 (fr)
CN (1) CN1222856A (fr)
AU (1) AU6819898A (fr)
CA (1) CA2259986A1 (fr)
DE (1) DE19708643C2 (fr)
EA (1) EA001107B1 (fr)
WO (1) WO1998036758A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10248601B4 (de) * 2002-10-17 2006-05-24 Goldstein, Naum, Dr.habil.nat. Pharmazeutisches Mittel zur endonasalen Applikation bei der Behandlung von Krankheiten und Störungen des zentralen Nervensystems
RU2253461C1 (ru) * 2004-04-30 2005-06-10 Общество с ограниченной ответственностью "Паркинфарм" Фармацевтическая комбинация, оказывающая влияние на функционирование цнс, способ коррекции состояний, связанных с нарушениями функционирования цнс; фармацевтический набор; средство, способствующее проникновению через гематоэнцефалический барьер лекарственных субстанций и метаболитов; фармацевтическое средство для эндоназального применения

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4112459A1 (de) * 1991-04-12 1992-10-15 Naum Dr Goldstein Verfahren und einrichtung zur erzeugung von definierten ionisierten gasen bzw. gasgemischen
CA2084725A1 (fr) * 1992-02-06 1994-06-08 Albert Roussy Solution therapeutique a usage externe

Also Published As

Publication number Publication date
EP0910392A2 (fr) 1999-04-28
WO1998036758A3 (fr) 1998-12-23
WO1998036758A2 (fr) 1998-08-27
EA199800941A1 (ru) 1999-06-24
AU6819898A (en) 1998-09-09
EA001107B1 (ru) 2000-10-30
DE19708643A1 (de) 1998-08-27
CN1222856A (zh) 1999-07-14
DE19708643C2 (de) 1999-04-15

Similar Documents

Publication Publication Date Title
AU757361B2 (en) Use of xenon for treating neurointoxications
JP6234899B2 (ja) 喘息及びアレルギー性鼻炎の治療におけるアルギナーゼ阻害剤の使用
KR20100028530A (ko) 폐 계면활성제의 투여 방법
US20090182055A1 (en) Fungicidal agent containing n-chlorotaurine and use thereof
JP2013510187A (ja) 誘発されたジスキネジアを治療又は予防するためのキセノンベースの吸入可能薬物
Remsen et al. Laser lateralization for bilateral vocal cord abductor paralysis
JPH0232023A (ja) パーキンソン症候群の治療用薬剤
TWI362260B (en) Medicament for preventing and/or treating peripheral neuropathies
CA2259986A1 (fr) Radicaux a anions oxygene et/ou substances therapeutiques contenant leurs produits de reaction et de degradation et leur utilisation dans le traitement de la maladie de parkinson
WO2005039600A2 (fr) Emploi du xenon pour contrer la mort programmee des cellules
NZ306832A (en) Compositions for treating mammalian diseases caused by inflammatory response
JPWO2019082428A1 (ja) 認知症の予防及び／又は治療剤
Hagen An approach to cough in cancer patients
CA2500090A1 (fr) Produit pharmaceutique a application endonasale pour traiter des maladies et des troubles du systeme nerveux central
CN107982321A (zh) 一种鼻塞用通气油及其制备方法和应用
Andreatta‐van Leyen et al. Cardiorespiratory effects induced by acetazolamide on the ventromedullary surface of the cat.
US20220073503A1 (en) Nitric oxide donor and anti-oxidant compounds
CN106535905A (zh) 用于控制中枢神经系统中肿瘤增殖的氙与nmda受体拮抗剂的组合
RU2236857C2 (ru) Способ лечения атрофии мозга, гидроцефалии мозга препаратом ветом-7048
WO2000010576A1 (fr) Procede d'elaboration de moyens de traitement du corps humain
Tari et al. CONSCIOUS SEDATION AND PAIN CONTROL IN DENTAL SURGERY WITH NITROUS OXIDE: CLINICAL PROTOCOL
RU2190400C2 (ru) Способ лечения респираторного дистресс-синдрома
SU1724249A1 (ru) Способ лечени острой дыхательной недостаточности
SU839537A1 (ru) Способ лечени неврозов
Liao et al. NSC23766, A Specific Inhibitor of Rac1 GTPase, Attenuated Delayed Neuronal Cell Death and Cognitive Deficit in Rats with Cardiac Arrest

Legal Events

Date Code Title Description
FZDE Dead